An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine. (Q39784264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

M-D Lai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

C-S Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

C-R Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

S-Y Yuan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

J-J Tsai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

C-F Tu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

C-C Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

C-C Lin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

23 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

203-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/cgt.2009.65

10 February 2020

exact match

0 references

cites work

DNA vaccines: successes and limitations in cancer and infectious disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

DNA vaccines: Vector design, delivery, and antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Autologous neu DNA vaccine can be as effective as xenogenic neu DNA vaccine by altering administration route

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Control of cytomegalovirus lytic gene expression by histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Targeting histone deacetylase in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Activation of CMV promoter-controlled glycosyltransferase and beta -galactosidase glycogenes by butyrate, tricostatin A, and 5-aza-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Trichostatin-A enhances adaptive immune responses to DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Delivery of noncarrier naked DNA vaccine into the skin by supersonic flow induces a polarized T helper type 1 immune response to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Reporter gene expression in dendritic cells after gene gun administration of plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Connective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Inhibitor of heat-shock protein 90 enhances the antitumor effect of DNA vaccine targeting clients of heat-shock protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

7 January 2021

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

7 January 2021

Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

7 January 2021

Antigen-bearing Langerhans cells in skin draining lymph nodes: phenotype and kinetics of migration

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

7 January 2021

CpG motifs induce Langerhans cell migration in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.65

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19851354%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference